Jeppe Øvlesen
Amministratore Delegato presso SYNACT PHARMA AB
Provenienza dei contatti di primo grado di Jeppe Øvlesen
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
| Public Company | Pharmaceuticals: Major | 17 | |
Neurescue ApS
 Neurescue ApS Medical SpecialtiesHealth Technology Neurescue ApS develops innovative medical devices for the treatment of cardiac arrest. It offers new platform of treatment methods for paramedics, nurses and doctors alike. The company was founded by Habib Frost in 2013 and is headquartered in Copenhagen, Denmark.
7
| Holding Company | Medical Specialties | 7 |
ResoTher Pharma AS
 ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors.
7
| Private Company | Pharmaceuticals: Major | 7 |
Action Pharma A/S
 Action Pharma A/S BiotechnologyHealth Technology Action Pharma A/S is an R&D-focused biotech company located in the Nordic Medicon Valley area in Copenhagen, Denmark. Action Pharma was founded in 2000 and has a pipeline of 4 drug candidates in different stages of development, plus additional compounds in discovery and early preclinical development. Action Pharma pursues the discovery and development of new drugs and treatment concepts to treat cardiovascular diseases, inflammatory diseases and metabolic diseases, such as type-II diabetes and obesity. Its drug candidates are modified endogenous peptides with improved efficacy and small chemical entities targeted the melanocortin receptors. In disease models, its drug candidates have shown strong effects in treating and preventing inflammation and organ damage in conditions such as post-surgical organ dysfunction and acute myocardial infarction. A major focus for Action Pharma is treatment candidates for type-II diabetes, obesity and metabolic syndrome. Moreover, several drug candidates have shown effects in treating inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and dermatitis.
6
| Extinct | Biotechnology | 6 |
Cercare Medical A/S
 Cercare Medical A/S Packaged SoftwareTechnology Services Cercare Medical ApS provides automated identification of viable tissue in acute stroke. It develops technology within medical image processing and image database analytics. The firm creates diagnostic software. The company was founded by Kim Mouridsen and Mikkel Bo Hansen in October 2013 and is headquartered in Aarhus, Denmark.
4
| Holding Company | Packaged Software | 4 |
Go-PEN Aps
 Go-PEN Aps Medical SpecialtiesHealth Technology Go-Pen ApS develops insulin pen. The Danish company was founded in 2019 by Ole Kjerkegaard Nielsen, Michael Ejstrup Hansen. Ole Kjerkegaard Nielsen has been the CEO since 2019.
4
| Holding Company | Medical Specialties | 4 |
CPHI-Holding A/S
 CPHI-Holding A/S Miscellaneous Commercial ServicesCommercial Services CPHI-Holding A/S is a Danish company based in Rodovre, Denmark. The CEOs are Michael Østerlund Madsen, Peter Scheuer Jensen. CPHI-Holding develops airport solutions to enhance passenger experience, including security scanner systems, intelligent trolleys, and baggage handling technologies. The private company has a team of over 30 employees. The company was founded in 1999 by Lars Hojgaard Thogersen, Søren Jakobsen, Rasmus Halfdan Breck.
4
| Private Company | Miscellaneous Commercial Services | 4 |
NordEnergie Renewables A/S
 NordEnergie Renewables A/S Electric UtilitiesUtilities NordEnergie Renewables A/S is a holding company that supplies households with pure and renewable energy. It is an independent power producer of wind power, an alternative to the traditional ways of generating energy. The firm owns and operates wind parks situated in Germany and Sweden. The company was founded in November 2007 and is headquartered in Copenhagen, Denmark.
1
| Extinct | Electric Utilities | 1 |
Vintage Cloud A/S
 Vintage Cloud A/S Electronics DistributorsDistribution Services Vintage Cloud ApS engages in the wholesale of computers, peripherals, and software. The firm’s purpose is the development and sale of archive systems and related activities. The company was founded on February 21, 2012 and is headquartered in Copenhagen, Denmark.
1
| Extinct | Electronics Distributors | 1 |
| Public Company | Medical Specialties | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jeppe Øvlesen tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| COLOPLAST A/S | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| NTG NORDIC TRANSPORT GROUP A/S | Trucking | Director/Board Member Corporate Officer/Principal | |
| MEDIVIR AB | Pharmaceuticals: Major | Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| AMBU A/S | Medical Specialties | Chairman Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| ALK-ABELLÓ A/S | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
| OREXO AB | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| The University of Edinburgh | College/University | Director/Board Member Graduate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree Masters Business Admin Masters Business Admin | |
| Stockholm School of Economics | College/University | Undergraduate Degree Masters Business Admin | |
| University of Uppsala | College/University | Doctorate Degree Masters Business Admin | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| University of Aarhus | College/University | Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Technical University of Denmark | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| University of Lund | College/University | Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Graduate Degree | |
| University of Copenhagen | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| International Institute for Management Development | College/University | Undergraduate Degree Masters Business Admin | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Founder Founder | |
SEED Capital Management I/S
 SEED Capital Management I/S Investment ManagersFinance SEED Capital Management I/S is an Independent Venture Capital firm founded in 2004. The company is headquartered in Copenhagen, Denmark. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Gothenburg | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Chief Investment Officer Corporate Officer/Principal | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Co-Ro Food A/S
 Co-Ro Food A/S Beverages: Non-AlcoholicConsumer Non-Durables Co-Ro Food A/S manufactures and wholesales soft drinks. The firm offers sunquick, top, cola, lolly and sunjoy brands. The company was founded in 1942 and is headquartered in New Castle, Denmark. | Beverages: Non-Alcoholic | Director/Board Member | |
Intomics A/S
 Intomics A/S Miscellaneous Commercial ServicesCommercial Services Intomics A/S provides data analysis solutions to data intensive research projectsa. Its services include advisory service, data analysis, and knowledge management. The firm helps clients in the pharmaceutical industry discover novel and drug targets, identify innovative and discriminative biomarkers, and enhance understanding of the underlying disease-biology at molecular level. The company was founded by Soren Brunak, Kasper Lage, Rasmus Wernersson and Thomas Skot Jensen in 2008 and is headquartered in Kongens Lyngby, Denmark. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Vendsyssel Seafood A/S | Director/Board Member | ||
Medichanical Engineering ApS
 Medichanical Engineering ApS Medical SpecialtiesHealth Technology Medichanical Engineering ApS provides orthopedic measuring tool for hip implant surgery. The firm has developed a mechanical measuring device-X-pander-that helps to objectify the operating surgeon’s decisions regarding cup-size and reaming of the acetabulum. Its X-pander works by inserting the hemispherical measuring-head into the reamed acetabulum for artificial hip-joints. The company was founded by Eske W.Petersen, Søren G. Buch, and Poul T. Nielsen in 2011 and is headquartered in Vejle, Denmark. | Medical Specialties | Director/Board Member Chairman | |
Observe Medical ApS
 Observe Medical ApS Medical SpecialtiesHealth Technology Observe Medical ApS develops medical devices for digital monitoring of a patients’ urine output. Its brands include sippsense, sippcoat, sippbag, and sipplink. The company was founded on June 26, 2010 and is headquartered in Kongens Lyngby, Denmark. | Medical Specialties | Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
MotilityCount ApS
 MotilityCount ApS Medical SpecialtiesHealth Technology MotilityCount ApS provides disposable sperm test measuring quality and quantity. It creates a home test that could give valid results on male fertility. The company was founded by Jacob Møllenbach Larsen, Nicolas Hojer Nielsen and Steen Broch Laursen in 2010 and is headquartered in Valby, Denmark. | Medical Specialties | Chairman | |
| ApS af 14. Juli 1984 | Chief Executive Officer | ||
| City Renovation A/S | Director/Board Member | ||
| Omega-Group A/S | Chairman | ||
Nanovi Radiotherapy A/S
 Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
NociTech ApS
 NociTech ApS BiotechnologyHealth Technology NociTech ApS develops a novel pain assessment platform for pain treatment. It provides a test platform to quantify pain sensitivity in patients and profile new analgesic compounds under development. The company was founded by Lars Arendt-Nielsen on July 11, 2013 and is headquartered in Aalborg, Denmark. | Biotechnology | Director/Board Member Chairman | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member | |
ADCendo ApS
 ADCendo ApS BiotechnologyHealth Technology ADCendo ApS is a Danish company that is focused on developing antibody-drug conjugates (ADCs) to treat underserved cancers. The company is based in Humlebaek, Denmark. The company completed a series A extension financing round in 2023, which brought its funds to 82 million EUR to advance into clinical development. The investors in the company include Novo Holdings, Ysios Capital, Pontifax Venture Capital, RA Capital Management, HealthCap, and Gilde Healthcare. The company was founded in 2017 by Christoffer Nielsen, Henrik Stage. Michael Pehl has been the CEO of the company since 2021. | Biotechnology | Founder Chairman | |
| ProTerapi Holding ApS | Chairman | ||
Biothea Pharma, Inc.
 Biothea Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Biothea Pharma, Inc. is an American biotechnology company that operates in the field of pharmaceuticals. The private company was founded by John F. Vavricka. Marina S. Bozilenko has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Co-Ro Holding A/S
 Co-Ro Holding A/S MiscellaneousMiscellaneous Part of CO-ROS Fond, Co-Ro Holding A/S is a Danish company that specializes in producing high-quality fruit-based products. The company is based in Frederikssund City, Denmark. The company's outstanding taste and compelling brand experiences have made them popular in over 80 countries. | Miscellaneous | Director/Board Member | |
| TXP Pharma GmbH | Founder Founder Founder Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Danimarca | 31 |
| Svezia | 16 |
| Regno Unito | 3 |
| Svizzera | 2 |
| Stati Uniti | 2 |
Settori
| Health Technology | 21 |
| Consumer Services | 12 |
| Finance | 7 |
| Commercial Services | 5 |
| Transportation | 2 |
Posizioni
| Director/Board Member | 261 |
| Chairman | 149 |
| Corporate Officer/Principal | 116 |
| Chief Executive Officer | 61 |
| Founder | 35 |
Contatti più connessi
| Insiders | |
|---|---|
| Preben Edvard Kønig | 58 |
| Frank Armstrong | 41 |
| Niels Erik Nielsen | 39 |
| Thomas Knudsen | 33 |
| Torbjørn Bjerke | 27 |
| Björn Westberg | 21 |
| Uli Alf Hacksell | 20 |
| Lene Gerlach | 20 |
| Terje Kalland | 20 |
| Thomas Feldthus | 20 |
| Jón Ingi Benediktsson | 19 |
| Kirsten Drejer | 18 |
| Nils Thomas von Koch | 17 |
| Anders Kronborg | 17 |
| John Sørensen Haurum | 17 |
- Borsa valori
- Insiders
- Jeppe Øvlesen
- Connessioni Società
